Sucampo Pharmaceuticals Company Profile (NASDAQ:SCMP)

About Sucampo Pharmaceuticals

Sucampo Pharmaceuticals logoSucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on research and development of drugs to treat gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It operates through development and commercialization of pharmaceutical products segment. Its operations are conducted through Sucampo AG, based in Zug, Switzerland, through which the Company conducts certain worldwide and European operations; Sucampo Pharma, LLC, based in Tokyo and Osaka, Japan and R-Tech Ueno, Ltd., based in Kobe, Japan, through which the Company conducts its Asian operations; Sucampo Pharma Americas LLC, based in Rockville, Maryland, through which the Company conducts operations in North and South America, and Sucampo Pharma Europe, Ltd., based in Oxford, the United Kingdom. It offers AMITIZA for the treatment of constipation and RESCULA for the lowering of intraocular pressure (IOP). Its products under development include cobiprostone, RTU-1096 and RTU-009.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: SCMP
  • CUSIP: 86490910
Key Metrics:
  • Previous Close: $12.34
  • 50 Day Moving Average: $12.67
  • 200 Day Moving Average: $11.66
  • 52-Week Range: $9.59 - $21.27
  • Trailing P/E Ratio: 43.54
  • Foreward P/E Ratio: 9.05
  • P/E Growth: 0.95
  • Market Cap: $531.27M
  • Outstanding Shares: 42,810,000
  • Beta: 1.57
  • Net Margins: 6.65%
  • Return on Equity: 42.18%
  • Return on Assets: 11.68%
  • Debt-to-Equity Ratio: 1.64%
  • Current Ratio: 4.27%
  • Quick Ratio: 3.89%
Additional Links:
Companies Related to Sucampo Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Sucampo Pharmaceuticals (NASDAQ:SCMP) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $19.78 (61.85% upside)

Analysts' Ratings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateFirmActionRatingPrice TargetDetails
9/7/2016Northland SecuritiesInitiated CoverageOutperform$15.00View Rating Details
8/4/2016Jefferies GroupLower Price TargetHold$16.00 -> $14.00View Rating Details
8/4/2016MizuhoDowngradeBuy -> Neutral$13.00View Rating Details
8/1/2016Maxim GroupLower Price TargetBuy$26.00 -> $17.00View Rating Details
7/12/2016Roth CapitalReiterated RatingBuyView Rating Details
5/5/2016WallachBeth CapitalUpgradeHold -> Buy$16.00View Rating Details
5/4/2016GuggenheimReiterated RatingBuy$29.00View Rating Details
3/17/2016Leerink SwannReiterated RatingMarket Perform$17.00View Rating Details
11/6/2015HC WainwrightLower Price Target$36.00 -> $28.00View Rating Details
5/7/2015Cantor FitzgeraldDowngradeBuy -> Hold$18.00View Rating Details
3/2/2015Credit Suisse Group AGDowngradeNeutral -> Underperform$10.00 -> $13.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2016Q216$0.22$0.23$48.33 million$52.00 millionViewListenView Earnings Details
5/4/2016Q116$0.19$0.21$44.11 million$47.20 millionViewListenView Earnings Details
3/8/2016Q415$0.19$0.43$42.72 million$55.40 millionViewListenView Earnings Details
11/4/2015Q315$0.18$0.16$36.18 million$33.50 millionViewListenView Earnings Details
8/5/2015Q215$0.15$0.21$31.90 million$34.90 millionViewListenView Earnings Details
5/6/2015Q114$0.14$0.14$30.19 million$29.50 millionViewListenView Earnings Details
3/4/2015Q413$0.17$0.21$37.23 million$37.80 millionViewListenView Earnings Details
11/6/2014Q313$0.04$0.03$26.11 million$31.50 millionViewListenView Earnings Details
8/5/2014Q213$0.03$0.04$24.06 million$24.10 millionViewListenView Earnings Details
5/7/2014Q113$0.04$0.02$24.19 million$22.20 millionViewListenView Earnings Details
2/26/2014Q4($0.04)$0.06$22.75 million$24.50 millionViewListenView Earnings Details
3/13/2013Q4 2012$0.12$0.32$32.21 million$34.90 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Current Year EPS Consensus Estimate: $1.03 EPS
Next Year EPS Consensus Estimate: $1.35 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.19$0.26$0.21
Q2 20165$0.20$0.29$0.25
Q3 20164$0.25$0.32$0.28
Q4 20164$0.31$0.38$0.35
(Data provided by Zacks Investment Research)


Dividend History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Insider Ownership Percentage: 3.31%
Institutional Ownership Percentage: 40.63%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/28/2015Daniel P. GetmanDirectorSell30,000$28.14$844,200.00View SEC Filing  
7/20/2015Thomas J KnappInsiderSell64,528$23.43$1,511,891.04View SEC Filing  
3/12/2015William AshtonDirectorSell55,762$17.55$978,623.10View SEC Filing  
3/11/2015Anthony C CelesteDirectorSell65,966$17.34$1,143,850.44View SEC Filing  
12/16/2014Cary J ClaiborneCFOSell50,000$12.91$645,500.00View SEC Filing  
12/15/2014Cary J ClaiborneCFOSell7,100$12.89$91,519.00View SEC Filing  
8/7/2014Sachiko KunoMajor ShareholderSell181,727$6.28$1,141,245.56View SEC Filing  
8/4/2014Ryuji UenoMajor ShareholderSell140,873$6.02$848,055.46View SEC Filing  
7/31/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  
7/30/2014S&R Technology Holdings, LlcMajor ShareholderSell300$6.25$1,875.00View SEC Filing  
7/25/2014Ryuji UenoMajor ShareholderSell16,155$6.26$101,130.30View SEC Filing  
7/23/2014Ryuji UenoMajor ShareholderSell5,845$6.29$36,765.05View SEC Filing  
7/22/2014S&R Technology Holdings, LlcMajor ShareholderSell2,500$6.25$15,625.00View SEC Filing  
7/21/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  
7/18/2014S&R Technology Holdings, LlcMajor ShareholderSell15,000$6.27$94,050.00View SEC Filing  
4/29/2014S&R Technology Holdings, Llcmajor shareholderSell113,600$6.65$755,440.00View SEC Filing  
4/25/2014Sachiko Kunomajor shareholderSell118,700$6.69$794,103.00View SEC Filing  
3/18/2014Gayle DolecekDirectorSell1,200$8.03$9,636.00View SEC Filing  
2/27/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  
1/17/2014Ryuji UenoCEOSell360,000$10.36$3,729,600.00View SEC Filing  
1/7/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  
10/16/2013Sachiko KunoMajor ShareholderSell360,000$6.35$2,286,000.00View SEC Filing  
9/18/2013Ryuji UenoCEOSell38,462$5.69$218,848.78View SEC Filing  
9/3/2013Ryuji UenoCEOSell38,462$5.59$215,002.58View SEC Filing  
8/19/2013Ryuji UenoCEOSell38,462$6.04$232,310.48View SEC Filing  
8/6/2013Sachiko Kunomajor shareholderSell38,462$6.21$238,849.02View SEC Filing  
7/24/2013Ryuji UenoCEOSell38,462$6.52$250,772.24View SEC Filing  
7/9/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.48$249,233.76View SEC Filing  
6/24/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.61$254,233.82View SEC Filing  
6/10/2013Sachiko KunoMajor ShareholderSell38,462$7.29$280,387.98View SEC Filing  
5/28/2013Ryuji UenoCEOSell38,462$8.79$338,080.98View SEC Filing  
5/21/2013Cary J ClaiborneCFOSell4,640$9.52$44,172.80View SEC Filing  
5/20/2013Stanley G MieleSVPSell6,400$9.60$61,440.00View SEC Filing  
5/16/2013Stanley G MieleSVPSell48,600$9.67$469,962.00View SEC Filing  
5/15/2013Timothy I MaudlinDirectorBuy32,870$9.82$322,783.40View SEC Filing  
5/13/2013Sachiko KunoMajor ShareholderSell38,462$9.27$356,542.74View SEC Filing  
2/4/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$5.22$200,771.64View SEC Filing  
12/26/2012S&R Technology Holdings, LlcMajor ShareholderSell20,262$5.01$101,512.62View SEC Filing  
11/27/2012Sachiko KunoMajor ShareholderSell12,205$5.00$61,025.00View SEC Filing  
11/13/2012Sachiko KunoMajor ShareholderSell11,962$5.00$59,810.00View SEC Filing  
11/1/2012Sachiko KunoMajor ShareholderSell37,595$5.06$190,230.70View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Sucampo Pharmaceuticals (NASDAQ:SCMP)
News IconSucampo Pharmaceuticals, Inc. (SCMP) Updated Broker Price Targets - The De Soto Edge (NASDAQ:SCMP) - October 25 at 12:26 PM
News IconAppraising The Value of These Shares: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - CSZ News (NASDAQ:SCMP) - October 20 at 7:31 PM
News IconAnalysts Weigh in on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): Consensus Notes - Recall News (NASDAQ:SCMP) - October 19 at 2:34 PM
News IconWhat are Analysts Expecting for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Earnings? - CSZ News (NASDAQ:SCMP) - October 19 at 2:34 PM
News IconAnalysts Set Sucampo Pharmaceuticals Inc. (SCMP) PT at $18.11 ... - DailyQuint (NASDAQ:SCMP) - October 17 at 7:03 PM logoSucampo Pharmaceuticals Q3: Surprise Likely - Seeking Alpha (NASDAQ:SCMP) - October 17 at 7:03 PM
News IconBargain-Counter Stock or Pricey? Update on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - CSZ News (NASDAQ:SCMP) - October 13 at 7:23 PM
News IconSucampo Pharmaceuticals, Inc. (SCMP) Updated Analyst Coverage - NewsDen (NASDAQ:SCMP) - October 10 at 11:58 AM
News IconSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Flunk Its Lead Experimental Drug - (NASDAQ:SCMP) - October 5 at 7:05 PM
News IconSucampo Pharmaceuticals, Inc. (SCMP) Latest Broker Views - NewsDen (NASDAQ:SCMP) - October 4 at 11:56 AM logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : October 3, 2016 (NASDAQ:SCMP) - October 3 at 11:50 AM
News IconBroker Roundup For Sucampo Pharmaceuticals, Inc. (SCMP) - The De Soto Edge (NASDAQ:SCMP) - September 29 at 12:36 PM logoShares Of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Expected To Hit $29 - Investor Newswire (NASDAQ:SCMP) - September 25 at 2:22 PM logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : September 23, 2016 (NASDAQ:SCMP) - September 23 at 11:55 AM
News IconShares Have Ticked Up Over the Last Five Trading Sessions: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Post News (NASDAQ:SCMP) - September 20 at 12:31 PM logoExpected For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Sales Of $267.07 - Investor Newswire (NASDAQ:SCMP) - September 14 at 11:36 AM
News IconAnalysts Place Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Under the Lens of the Microscope - Post News (NASDAQ:SCMP) - September 12 at 6:49 PM logoSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCMP-US : September 7, 2016 (NASDAQ:SCMP) - September 7 at 10:52 AM logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : September 2, 2016 (NASDAQ:SCMP) - September 2 at 12:06 PM
News IconShares Down for the Quarter: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Post News (NASDAQ:SCMP) - August 28 at 11:07 AM
News IconShares Holding Above Moving Averages: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Post News (NASDAQ:SCMP) - August 24 at 6:59 PM logoSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Reports Sales Of $51.951, Surprising Estimates By 7.759% - Investor Newswire (NASDAQ:SCMP) - August 23 at 7:27 PM logoWill Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Hit $29 Price Target? - Investor Newswire (NASDAQ:SCMP) - August 22 at 11:54 AM logoSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : August 22, 2016 (NASDAQ:SCMP) - August 22 at 11:54 AM logoAnalysts See Sales Of $267.07 For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Investor Newswire (NASDAQ:SCMP) - August 16 at 7:25 PM logoETF’s with exposure to Sucampo Pharmaceuticals, Inc. : August 15, 2016 (NASDAQ:SCMP) - August 15 at 7:42 PM logoSUCAMPO PHARMACEUTICALS, INC. Financials (NASDAQ:SCMP) - August 11 at 7:51 PM logoSucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:SCMP) - August 10 at 7:51 PM logoSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:SCMP) - August 8 at 7:32 PM logoSucampo Pharmaceuticals Inc. (SCMP) Drops 9.43% on August 04 (NASDAQ:SCMP) - August 6 at 10:01 AM logoSucampo Pharmaceuticals Inc. (SCMP) Drops 9.43% on August 04 - (NASDAQ:SCMP) - August 5 at 7:33 PM logoSucampo Pharmaceuticals, Inc.: Gathering momentum, can it sustain its performance? (NASDAQ:SCMP) - August 4 at 7:47 PM logoEdited Transcript of SCMP earnings conference call or presentation 3-Aug-16 12:30pm GMT (NASDAQ:SCMP) - August 4 at 10:31 AM logoSucampo Pharma downgraded by Mizuho (NASDAQ:SCMP) - August 4 at 10:31 AM logoSucampo reports 2Q loss (NASDAQ:SCMP) - August 3 at 10:36 AM logoSucampo Reports Second Quarter 2016 Financial Results (NASDAQ:SCMP) - August 3 at 10:36 AM logoQ2 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open (NASDAQ:SCMP) - August 3 at 10:36 AM logoSucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:SCMP) - August 3 at 10:36 AM logoPaul Edick Joins Sucampo’s Board of Directors (NASDAQ:SCMP) - July 29 at 6:48 AM logoSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure (NASDAQ:SCMP) - July 29 at 6:36 AM
News IconHow Analysts Rated Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Last Week? - Press Telegraph (NASDAQ:SCMP) - July 22 at 7:05 PM logoSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Expected To Post Sales Of $371.307 - Investor Newswire (NASDAQ:SCMP) - July 21 at 7:39 PM
News IconSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:SCMP) - July 21 at 7:39 PM logoSucampo Pharmaceuticals Inc Realized Volatility Hits A Lowered Level - CML News (NASDAQ:SCMP) - July 21 at 7:39 PM
News IconWill Investors Find Any Relief with Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - TGP (NASDAQ:SCMP) - July 21 at 7:39 PM logoSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.26% on July 20 - (NASDAQ:SCMP) - July 21 at 7:39 PM logoSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.26% on July 20 (NASDAQ:SCMP) - July 20 at 8:13 PM logoSucampo Announces Second Quarter 2016 Earnings Call (NASDAQ:SCMP) - July 20 at 6:45 AM logoThis Impressive Small-Cap Pharma Is Set For Its Next Big Move (NASDAQ:SCMP) - July 19 at 1:30 PM logoNew Broker Ratings For Sucampo Pharmaceuticals, Inc. (SCMP) - FTSE News (NASDAQ:SCMP) - July 19 at 8:25 AM


Sucampo Pharmaceuticals (NASDAQ:SCMP) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by Staff